Drug Repackagers Could Be Liable For Medicaid Rebates Due To Pending FDA Rule
This article was originally published in The Pink Sheet Daily
Executive Summary
Rule could shift some rebates from drug manufacturers to repackagers, due to change in products’ national drug code.